Skip to content
Homepage
Author:
Tarsus Pharmaceuticals, Inc
Posted Date:
August 6, 2026
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
Tarsus Pharmaceuticals, Inc
August 6, 2026
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Tarsus Pharmaceuticals, Inc
August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
Tarsus Pharmaceuticals, Inc
August 6, 2026
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Tarsus Pharmaceuticals, Inc
August 6, 2026
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
Tarsus Pharmaceuticals, Inc
July 13, 2026
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
Tarsus Pharmaceuticals, Inc
July 8, 2026
Tarsus to Participate in Upcoming Investor Conferences
Tarsus Pharmaceuticals, Inc
May 28, 2026
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
Tarsus Pharmaceuticals, Inc
May 14, 2026
Tarsus to Participate in Upcoming Investor Conferences
Tarsus Pharmaceuticals, Inc
May 7, 2026
Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements
Tarsus Pharmaceuticals, Inc
May 6, 2026
1
2
Next
